Introduction 34
Multiple epiphyseal dysplasia (MED, MIM 132400) is a genotypically and 35 phenotypically heterogeneous skeletal dysplasia and chondrodysplasia that affects 36 epiphysis of long bones [1, 2] . MED is characterized by early-onset arthritis, especially in 37 hip and knee joints, which results in joint pain and stiffness, waddling gait in early 38 childhood, and mild to moderate shortness of stature. Eight disease genes, which may 39 be inherited in an autosomal dominant or recessive pattern, have been identified. 40 8 plates from birth. The number of chondrocytes in the tibial growth plates were reduced 139 in these mice than Smoc2 +/+ mice ( Figure. 3B-D) and they were disorganized and failed 140 to arranged into a column, so hypocellular areas could be observed in the proliferative 141 zones and hyaline cartilage of proximal tibia ( Figure. 3A) . 142
On transmission electron microscopy of tibial growth plates of P21 mice, the cisternae 143 of rER in the chondrocytes were well organized and folded. However, in mutant mice, 144 the cell nuclei in chondrocytes were deformed and the nuclear membrane was 145 saw-tooth-shaped. Mutant mice showed some seriously dilated cisternae of rER 146 containing retained proteins in the chondrocytes. Almost all chondrocytes of mutant 147 mice contained seriously dilated cisternae of rER (Figure. 3A) . 148
149

Smoc2
L359R/+ and Smoc2 L359R/L359R mice showed chondrocyte apoptosis and 150
hypertrophy spatially dysregulated 151
To determine the mechanism of the expansion of hypertrophic zones in mutant mice 152 tibial growth plates, we determined the relative levels of proliferation, apoptosis and 153 hypertrophy at P21. By using immunohistochemistry with proliferating cell nuclear 154 antigen (PCNA), a marker of proliferation, we found no significant differences in ratio 155 of PCNA-positive cells in both proliferative and hypertrophic zones from the tibial 156 growth plates ( Figure. Because BMP plays important role in initiation of chondrogenesis and previous study 175
showed that SMOC without EC domain inhibited BMP signalling [14] , we analyzed 176 whether mutant SMOC2 inhibited BMP signaling. We found that the number of 177 p-Smad1/5/9 positive cells decreased in primary chondrocytes and tibial growth plates 178 from mutant mice ( Figure. In previous study, SMOC1 could inhibit BMP signaling by activating the 187 mitogen-activated protein kinase (MAPK) pathway [14] . We used MG132 and BMP2 188 treated HEK293T cells stably transfected with or without wild SMOC2 cells ( In this study, we demonstrated a four-generation MED family with complicated 217 phenotypes and identified an unreported pathogenic gene, SMOC2, establishing a close 218 relationship of SMOC2 with MED for the first time. The missense mutation c.1076T>G 219 (p. Leu359Arg) of SMOC2 was suggested to be the causative variant. 220
Of note, we detected a meaningful phenotype, the enlarged hypertrophic zone in tibia 221 growth plates in the Smoc2 knock-in mice model, which had been observed in some 222 knockout mice models, including those deficient in Matn3 [15] , Smad3 [16] , and Fgf18 [17] . 223
The mechanisms of expanded hypertrophic zones are different. The expanded 224 hypertrophic zones in Matn3-deficient and Smad3-deficient mice were due to 225 accelerated differentiation of chondrocytes [7][16] . Both proliferative and hypertrophic 226 zones were expanded in Fgf18-deficient mice, which also displayed delayed 227 ossification and decreased expression of osteogenic markers [17] . In our study, 228 chondrocyte proliferation did not differ in all mice. Chondrocyte apoptosis was reduced 229 in the hypertrophic zones of tibial growth plates from mutant mice. Furthermore, the 230 increased expression of Ihh in mutant mice may be another reason for the expanded 231 hypertrophic zones. Whether this is related to delayed ossification and matrix 232 resorption needs further investigation. 233 SMOC2 has been found involved in cell cycle progression by maintaining 234 integrin-linked kinase activity during the G1 phase [18] . Both a homozygous mutation 235 (c.84þ1G>T) in the canonical-splice donor site of intron 1 and c.681T>A(p.C227X) 236 nonsense mutations in SMOC2 caused dental development defects [19, 20] . However, no 237 dental defects were observed in our family or the knock-in mouse model. Recent study 238 has shown that overexpressing SMOC2 in osteoprogenitor cells inhibits osteogenic 239 differentiation and ECM mineralization [21] . SMOC2 was also considered an antagonist 240 of BMP signaling. Study of zebrafish showed that Smoc2 can inhibit the transcription 241 of BMP target genes [22] . Another study of Xenopus and Drosophila showed that SMOC 242
can activate MAPK signals, thereby inhibiting the BMP signaling downstream of its 243 receptor, and can expand the range of BMP signaling by competing HSPG binding [14, 244 23] . 245 SMOC2 and its homologue SMOC1 contain an FS domain, two TY domains 246 separated by one SMOC domain, and an EC domain with two EF-hand 247 calcium-binding motifs family [12, 13] . The EC domain of BM-40 protein families have 248 diverse biological functions such as transducing signals of calcium as a secondary 249 signal, maintaining conformation by binding with calcium, and binding to collagenous 250 proteins [24] . Homozygous missense variants in the EC domain of BM-40 abolished the 251 affinity of BM-40 to collagen type I and caused recessive osteogenesis imperfecta type 252 IV [25] . Previous study has shown that the EC domain of SMOC2 is fully conserved and 253 is presumably important by binding calcium for the structure of SMOC2 [13, 26] . The 254 SMOC2 EC domain mediates cell attachment by binding to αvβ6 and αvβ1 integrins on 255 cell surface receptors [27] . In the present report, the Leu359Arg mutant in SMOC2 256 responsible for MED in our family is strictly conserved in evolution and is located in 257 the first EF-hand motif of the EC domain. When we first focused on the interaction of 258 SMOC2 and collagen IX, we found that the mutation could affect the interaction 259 affinity of SMOC2 and collagen IX. So, the reduced interaction between SMOC2 and 260 collagen IX may alter the biological function of collagen IX or SMOC2 and result in 261 this MED. Certainly, its detailed mechanism needs to be elucidated. 262 SMOC2 is an important structural anchor in the ECM networks of cartilage, like 263 other members of the BM40/SPARC family, but SMOC2 can also interact with 264 receptors on the cell surface, acting as a regulator of cell-matrix interaction to activate 265 or inactivate some signaling pathways. Previous evidence demonstrated that SMOC2 is 266 involved in the pathways fibroblast growth factor or vascular endothelial growth factor 267 signaling [28] , TGF-β1-SMAD2/3 [29, 30] , WNT/β-catenin [31] , and BMP-SMAD1/5/9 [14, 268 23, 32] , which play an important role in chondrogenesis. Considering the importance of 269 the BMP-SMAD1/5/9 pathway in endochondral bone formation [33] [34] [35] [36] , we assessed 270 whether the mutant Smoc2 affected the BMP-SMAD1/5/9 pathway. Our study 271 confirmed that overexpression of wild-type SMOC2 could antagonize BMP signaling, 272 and mutant SMOC2 overexpression still retained this antagonist property intact in vitro, 273 which was due to the mutant site located in the EC domain. In knock-in mice, 274 heterozygous and also homozygous mutant Smoc2 inhibited BMP signaling, which is 275 consistant with wild-type SMOC2 overexpression. So, we conclude that the pathogenic 276 mechanism in this MED family is inhibition of BMP signaling by the mutation (Figure. The SMOC EC (EC domain only) domain could bind HSPG with similar affinity to 279 BMP2. Low levels of SMOC competitively bound to HSPG and released BMP to bind 280 with BMPR and activate BMP signaling, whereas high amounts of SMOC both bound 281 HSPG and inhibited BMP signaling. We also found that the mutant SMOC2 EC 282 domain reduced or abolished the interaction of SMOC2 with collagen IX and HSPG, 283 which at least led to increased insoluble SMOC2 level in the ECM of cartilage. 284
In our study, inhibiting the overexpression of SMOC2 to BMP signaling was due to 285 neither increasing degradation of phospho-SMAD 1/5/9 nor MAPK-mediated 286 phosphorylation of the Smad linker region ( Figure 5-figure supplement 1B) . Rescue 287 experiments with the BMP receptors ACVR1, caBMPR1A and caBMPR1B further 288 suggests that its inhibition mainly depends on competitive BMP-receptor binding, 289 especially BMPR1B binding, which was not altered by the Leu359Arg mutant in the 290 SMOC2 EC domain. This contrasts with previous study finding that SMOC, mainly 291 SMOC1, acted downstream of the BMPR via MAPK-mediated phosphorylation of the 292 Smad linker region [14] . 293
In conclusion, our evidence supports that SMOC2 is a new MED-causative gene 294 and illustrates the importance of SMOC2 in the development of cartilage and long 295 bones. Ultimately, a complete understanding of the molecular genetics and cell-matrix 296 pathophysiology of MED will aid in the diagnosis, prognosis, and treatment of patients 297 and families with MED and will also help in understanding the disease mechanisms of 298 more common conditions such as osteoarthritis. 299 300
Materials and Methods 301
Family 302
We were contacted by a Chinese family that had several adults with short stature and 303 osteoarthritis. All patients in this family received a diagnosis of MED based on clinical 304 and radiography findings. Genomic DNA was extracted from peripheral venous blood 305 by using standard protocols. This study was approved by the medical ethics committees 306 of Shandong University, China and followed the principles of the Declaration of 307
Helsinki. Before the study initiation, written informed consent was obtained from 308 participating individuals. 309 310 Exome sequencing, variant filtration and mutation detection 311
We performed exome sequencing of DNA from patients II9, III14 and IV9 in this 312 family by using SureSelect Human All Exon Kit (Agilent, Santa Clara, CA) to capture 313 the exome and HiSeq2000 platform (Illumina, San Diego, CA) for sequencing. All 314 variations were filtered by using dbSNP137, the 1000 Genomes Project, and HapMap8 315 databases. Sanger sequencing was used to confirm the mutation in SMOC2 in this 316 family. PCR involved using 40 ng genomic DNA and Easy Taq (Transgen Biotech, 317
Beijing). The PCR products were sequenced by Biosune Biotechnology (Shanghai) and 318 compared with the reference sequence in NCBI (https://blast.ncbi.nlm.nih.gov). To 319 predict the detrimental effect caused by the mutation, bioinformatics analysis of the 320 p.Leu359Arg mutation involved using PolyPhen-2, Mutation Taster 321 (http://www.mutationtaster.org/) and SIFT. 322 323
Construction of the targeting vector and generation of chimeric mice 324
A targeting vector containing SMOC2 exon10, 11 and 12 and the mutation allele 325 flanked by a loxP site and a loxP-neo cassette was constructed, which was introducedinto mouse embryonic stem (ES) cells. After removing the cassette, the targeting ES 327 cells were injected into C57BL/ 6 (B6) blastocysts to generate chimeras (F0), which 328 were mated with C57BL/6 mice to generate F1 heterozygous offspring. Generation of 329 the mouse model was performed by Cyagen Biosciences (Guangzhou, China). The 330 genotypes of mice were determined by Sanger sequencing. The sequence containing 331 the mutation was amplified with primers (Table 4 ). The PCR products were sequenced 332 by Biosune Biotechnology (Shanghai) and compared with the reference sequence in 333
NCBI. 334 335
Cell culture 336
The cells The human embryonic kidney 293T (HEK293T) cell were cultured in DMEM 337 containing 10% FBS (Thermo Fisher Scientific), 100 U/ml penicillin (A603460, 338
Sangon Biotech, Shanghai) and 100 μg/ml streptomycin (A100382-0050, Sangon 339 Biotech) at 37℃ with 5% CO2. Primary chondrocytes were taken from the knees of P6 340
littermates. F-12 nutrient medium was purchased from Gibco (Thermo Fisher 341 Scientific). Cells were cultured in F12 containing 10% FBS at 37℃ with 5% CO2. 342 343
Cell transfection and treatment 344
Recombinant lentiviruses and stably transfected cell line were established as 345 described in previous study [37] . Stably transfected cells were seeded in a 100-mm 2 dish 346 at 80% density. After maintaining in DMEM with 10% FBS overnight, 4-12 μg 
Analysis of the skeleton 360
The body weights of littermates were measured on days 30 and 63. The body length 361 measurements were taken from X-ray radiographs by using X-RAD225 OptiMAX. The 362 lengths of isolated femurs and tibias were measured by using a vernier caliper. 363 364
Alizarin Red and Alcian Blue double-staining 365
The newborn littermates were sacrificed and the skin, muscle, viscera and soft tissues 366 were removed. After fixation in absolute ethanol and acetone, alcian blue (0.1%, visualized by ECL blotting detection reagents (32209, Thermo) and exposed to X-ray 437
films (SUPER RX-N-C, FUJIFILM). 438 439
Real time PCR (qRT-PCR) 440
Cartilages from proximal tibias were dissected from wild-type and mutant mice. Then 441 total RNA from cartilages was isolated by using TRIzol (Invitrogen) and cDNA was 442 generated by using random primers. Real time PCR was performed with the SYBR 443
Green Real Time PCR Master Mix (CW0957, CWBIO, CHN) and primers 444 (Supplemental Table S4 littermates were dissected and fixed in 4% PFA for 4 h. After a wash with 0.1 M sodium 464 cacodylate buffer for 3 times, the samples were fixed with 1% osmium tetroxide for 2 h 465 at room temperature. Samples were dehydrated through ascending ethanol series and 466 ethanol was replaced by acetone. Then samples were embedded with 812 embedding 467 medium and incubated for 48 h at 60℃. Samples were cut at 60-80 nm and stained with 468 uranyl acetate and lead citrate for 15 min and images were obtained by using an 469 HITACHI Transmission Electron Microscope (HT7700 into the matrix and more dissociative mutant SMOC2 competing with BMP2 for 717 BMPR1B and phosphorylation of SMAD1/5/9 was blocked. 718 
